Skip to content

Drug interactions

Candesartan-hydrochlorothiazide + Mycophenolate

Severity: Minor

Candesartan-hydrochlorothiazide and Mycophenolate: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Hydrochlorothiazide may compete with the renal tubular secretion of mycophenolic acid glucuronide, potentially raising exposure to mycophenolate metabolites. The clinical significance is uncertain.

What this interaction means in plain words

Candesartan-hydrochlorothiazide and Mycophenolate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Competition for renal tubular anionic secretion of the mycophenolic acid glucuronide.

What to do

No routine dose change is needed; monitor for mycophenolate adverse effects such as cytopenias and gastrointestinal toxicity.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Candesartan-hydrochlorothiazide and Mycophenolate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Candesartan-hydrochlorothiazide with Mycophenolate?

MediHelp rates the interaction as minor. Candesartan-hydrochlorothiazide and Mycophenolate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Hydrochlorothiazide may compete with the renal tubular secretion of mycophenolic acid glucuronide, potentially raising exposure to mycophenolate metabolites. The clinical significance is uncertain.

How serious is the interaction between Candesartan-hydrochlorothiazide and Mycophenolate?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor for mycophenolate adverse effects such as cytopenias and gastrointestinal toxicity.

What other medicines interact with Candesartan-hydrochlorothiazide?

MediHelp also lists interactions of Candesartan-hydrochlorothiazide with, for example, Aliskiren, Dofetilide, Sparsentan. The full list is on the Candesartan-hydrochlorothiazide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in